KRAS and neoplasm: To elucidate the differences in KRAS, ATR, CHEK1 mRNA expression levels between the two analyzed group of samples, we checked for their correlation with tumor grade differentiation and depth of myometrium invasion, which are key clinicopathological indicators of tumor progression.